WebDisclosure WebDisclosure
Basculer en Français
9815 Companies
196872 Keywords
127929 Articles
104694 Press releases
Headlines Articles Press releases APEIRON Biologics AG Remove
  1. Home
  2. Companies
  3. APEIRON Biologics AG
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 07/08/2024 at 16:20, 1 year 6 months ago

    APEIRON Biologics to be Acquired by Ligand Pharmaceuticals for USD 100 Million

    Acquisition Investment Biotech Immuno-oncology QARZIBA®
  • BRIEF

    published on 07/08/2024 at 16:20, 1 year 6 months ago

    APEIRON Biologics va être acquis par Ligand Pharmaceuticals pour 100 millions de dollars

    Acquisition Investissement Immuno-oncologie Biotechnologies QARZIBA®
  • PRESS RELEASE

    published on 07/08/2024 at 16:15, 1 year 6 months ago

    APEIRON Biologics to be Acquired by Ligand Pharmaceuticals for USD 100 Million

    APEIRON Biologics AG to be Acquired by Ligand Pharmaceuticals for USD 100 Million. Ligand will also invest up to USD 4 million in APEIRON spin-off, invIOs
    Acquisition Immuno-oncology Biotech Company APEIRON Biologics AG Ligand Pharmaceuticals
    Logo of APEIRON Biologics AG
Accesswire
  • Published on 02/05/2026 at 17:35, 56 minutes ago

    Pentagon I Capital Corp. Enters into Letter Agreement to Complete Qualifying Transaction with Prospectiva Resources Ltd.

  • Published on 02/05/2026 at 16:40, 1 hour 51 minutes ago

    Relevant Gold Appoints Larry Taddei to Board of Directors and Mal Karwowska as Strategic Advisor

  • Published on 02/05/2026 at 15:45, 2 hours 46 minutes ago

    American Critical Minerals Recaps a Highly Successful 6 Months and Files Amended and Restated Technical Report

  • Published on 02/05/2026 at 15:10, 3 hours 21 minutes ago

    Electric Metals (USA) Limited Announces Change of Auditor

  • Published on 02/05/2026 at 14:50, 3 hours 41 minutes ago

    High Tide Resources Announces Non-Brokered Private Placements

View all ACCESSWIRE
EQS Group
  • Published on 02/05/2026 at 18:09, 22 minutes ago

    Funding Circle Holdings plc: POS-Transaction in Own Shares

  • Published on 02/05/2026 at 17:55, 36 minutes ago

    Piramal Critical Care and Blue-Zone Technologies collaborate to capture, collect and recycle waste anaesthesia gas

  • Published on 02/05/2026 at 17:40, 51 minutes ago

    BROADPEAK SA: Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social au 01.02.26.

  • Published on 02/05/2026 at 17:40, 51 minutes ago

    UV GERMI : MISE À DISPOSITION DE LA NOTE D’INFORMATION ET DU DOCUMENT « AUTRES INFORMATIONS » DANS LE CADRE DE L’OFFRE PUBLIQUE DE RACHAT D’ACTIONS INITIÉE PAR UV GERMI

  • Published on 02/05/2026 at 17:05, 1 hour 26 minutes ago

    European Research and Innovation: the Politecnico di Milano Launches an Office in Brussels

View all EQS
Les Echos
  • Published on 02/05/2026 at 18:12, 19 minutes ago

    LNA SANTE : Chiffre d'affaires annuel 2025

  • Published on 02/05/2026 at 18:06, 24 minutes ago

    Aéroports de Paris SA - Actions et droits de vote au 31 janvier 2026

  • Published on 02/05/2026 at 18:06, 24 minutes ago

    Aéroports de Paris SA - Shares and voting rights as of 31 January 2026

  • Published on 02/05/2026 at 18:00, 31 minutes ago

    Information concerning the total number of voting rights and shares in the share capital as of January 30, 2026

  • Published on 02/05/2026 at 18:00, 31 minutes ago

    Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 30 janvier 2026

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy